Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)

Protocol No
NEURO-NINDS-CAPTIVA
Phase
III
Summary

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.

Description
Anti-coagulation vs Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL